Real Price to Acquire Entire Company: harmonybiosciences.com (HRMY)
Harmony Biosciences (HRMY) is actively expanding its portfolio of therapies for rare brain pathologies by acquiring promising biotech projects. The brand maintains absolute authority among medical professionals due to its effectiveness in treating sleep disorders. This price chart on GURU.Markets shows an Enterprise Value of 1800.52, while market capitalization depends on the volume of Wakix prescriptions and FDA approval for new indications.
Harmony Biosciences - analytical breakdowns and key metrics (HRMY)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- company total debt and liquidity indicators:
Debt to Capital Harmony Biosciences|HRMY - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital harmonybiosciences.com|HRMY - Company Debts|Debt to Net Assets Ratio Harmony Biosciences|HRMY - Company Long-Term Debt|Short-Term Debt Harmony Biosciences|Intermediate Coverage Ratio harmonybiosciences.com
- earnings and market multiples details:
Analysis of all company metrics:Harmony Biosciences Inc
Enterprise Value (EV) represents the total acquisition cost of a business, combining market capitalization and net debt. By analyzing the company's gross value, an investor sees the actual cost of acquiring the asset. For Harmony Biosciences (HRMY), this metric reflects the financial capacity for aggressive expansion of its orphan drug portfolio. The trend in the company's gross value confirms its readiness to acquire new biotech startups, allowing for an objective assessment of the efficiency of invested capital.
Competitors of Harmony Biosciences (HRMY)
Value Adjusted for Debt and Cash BIIB|NBIX - Total Company Value|Regencell Corp (RGC) - Real Price to Acquire Entire Company|AXSM (Axsome Therapeutics) - Real Price to Acquire Entire Company|Total Enterprise Value acadia-pharm.com (ACAD)|Total Company Value Xenon|Business Value VKTX (Viking Therapeutics Inc)|Enterprise Value SUPN|CPRX - Total Enterprise Value|Denali Therapeutics - Real Price to Acquire Entire Company|Enterprise Value biohavenpharma.com BHVN|AMLX - Total Company Value|Value Adjusted for Debt and Cash TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Total Company Value|Total Enterprise Value Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Enterprise Value|PRTA: Value Adjusted for Debt and Cash|Enterprise Value ALEC|Enterprise Value Annexon Biosciences (ANNX)|Total Company Value Omeros OMER|Value Adjusted for Debt and Cash NGNE|ACIU - Total Company Value|voyagertherapeutics.com (VYGR) - Real Price to Acquire Entire Company|Neumora Therapeutics, Inc. (NMRA) - Total Company Value|Total Enterprise Value Scilex Holding (SCLX)|Total Company Value Tevogen Bio Holdings, Inc.|Business Value ACOG (Alpha Cognition Corp)|Real Price to Acquire Entire Company CGTX (Cognition Therapeutics, Inc.)|IKT - Total Enterprise Value|Cassava Sciences - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash ASRT|Coya - Enterprise Value|VTGN: Total Company Value|OVID: Enterprise Value|ABOS - Company Buyout Price|Total Company Value CervoMed|Total Enterprise Value Alterity Therapeutics Ltd ATHE|Total Company Value Clene Inc. (CLNN)|Company Buyout Price pepgen.com|Enterprise Value JUNS (Jupiter Neurosciences)|RLMD - Real Price to Acquire Entire Company|Annovis Bio - Enterprise Value|Company Buyout Price Grace Therapeutics, Inc. GRCE|AIFF: Enterprise Value|Total Enterprise Value Klotho Neurosciences (KLTO)|Total Company Value NeuroSense Therapeutics Ltd|Business Value RVPH (revivapharma.com)|Enterprise Value MTVA|Real Price to Acquire Entire Company NeurAxis Inc. NRXS|Enterprise Value HSDT (Helius Medical Technologies)|Passage Bio Inc. (PASG) - Total Enterprise Value|NEUP - Total Company Value|Company Buyout Price minervaneurosciences.com NERV|ATHA: Enterprise Value|Addex Therapeutics Ltd. - Value Adjusted for Debt and Cash|Total Company Value Alzamend Neuro Inc.|CYCN: Value Adjusted for Debt and Cash|Total Company Value Protagenic Therapeutics (PTIX)|Real Price to Acquire Entire Company pasitheaclinics.com KTTA|Cortigent - Real Price to Acquire Entire Company|Avenue Therapeutics Inc. (ATXI) - Total Enterprise Value|BCLI - Total Company Value|CARA (Cara Therapeutics Inc) - Business Value|CHRO: Enterprise Value|Total Enterprise Value Eliem Therapeutics Inc. (ELYM)|Real Price to Acquire Entire Company ITCI|Enterprise Value Longboard Pharmaceuticals Inc|Total Company Value Marinus (MRNS)|NKGN (NKGen Biotech Corp) - Value Adjusted for Debt and Cash|Total Company Value NeuroBo Pharmaceuticals NRBO|sagerx.com (SAGE) - Total Enterprise Value|Synaptogenix - Enterprise Value|Value Adjusted for Debt and Cash TRVN (Trevena Inc.)|VIGL: Enterprise Value|anewmeds.com (WENA) - Enterprise Value|Total Company Value Cerevel Therapeutics